These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 9855431)
1. Long-term efficacy of pertussis vaccines in Italy. PROPER Study Working Group. Salmaso S; Anemona A; Mastrantonio P; Stefanelli P; Tozzi AE; Ciofi degli Atti ML Dev Biol Stand; 1998; 95():189-94. PubMed ID: 9855431 [No Abstract] [Full Text] [Related]
2. Japanese clinical experiences with acellular pertussis vaccines. Kimura M Dev Biol Stand; 1991; 73():5-9. PubMed ID: 1778333 [No Abstract] [Full Text] [Related]
3. How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy. Rota MC; D'Ancona F; Massari M; Mandolini D; Giammanco A; Carbonari P; Salmaso S; Ciofi degli Atti ML Vaccine; 2005 Nov; 23(46-47):5299-305. PubMed ID: 16112254 [TBL] [Abstract][Full Text] [Related]
4. Introduction to the International Symposium on Pertussis Evaluation and Research on Acellular Pertussis Vaccines. Oya A Dev Biol Stand; 1991; 73():3-4. PubMed ID: 1778323 [No Abstract] [Full Text] [Related]
5. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis. Gabutti G J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533 [No Abstract] [Full Text] [Related]
6. [Whooping-cough. Epidemiological, prognostic and prophylactic considerations on a series of recent cases]. Scarabicchi S; Giambartolomei G; Luzzati R Minerva Pediatr; 1981 Jun; 33(12):571-6. PubMed ID: 7266436 [No Abstract] [Full Text] [Related]
7. Has the change to acellular pertussis vaccine improved or worsened pertussis control? Halperin SA; De Serres G CMAJ; 2006 Nov; 175(10):1227. PubMed ID: 17098952 [No Abstract] [Full Text] [Related]
8. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Gustafsson L; Hessel L; Storsaeter J; Olin P Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988 [TBL] [Abstract][Full Text] [Related]
9. [The epidemiological impact of vaccination strategies in the Lazio Region]. Faustini A; Giorgi-Rossi P; Sangalli M; Spadea T; Perucci CA Ann Ig; 2002; 14(4 Suppl 4):39-49. PubMed ID: 12389423 [No Abstract] [Full Text] [Related]
10. Impact of routine vaccination with a pertussis toxoid vaccine in Denmark. Hviid A; Stellfeld M; Andersen PH; Wohlfahrt J; Melbye M Vaccine; 2004 Sep; 22(27-28):3530-4. PubMed ID: 15315832 [TBL] [Abstract][Full Text] [Related]
11. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children. Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of two pertussis vaccines in preterm Danish children. Hviid A Vaccine; 2009 May; 27(23):3035-8. PubMed ID: 19428916 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of pertussis and high expectations concerning vaccines]. Wysocki J Przegl Epidemiol; 2004; 58 Suppl 1():39-43. PubMed ID: 15807156 [TBL] [Abstract][Full Text] [Related]